What to watch with LDL and menopause?

During menopause, declining estrogen levels often lead to an increase in LDL cholesterol. Estrogen helps maintain a favorable lipid profile; its loss shifts balance toward higher LDL and smaller, denser particles that are more atherogenic. Additionally, insulin resistance may worsen, further disturbing lipid metabolism. Key monitoring should include a full lipid panel—not just LDL—plus non-HDL cholesterol and apolipoprotein B, as these markers better reflect risk in menopausal women. Consumer DNA tests for single SNPs (e.g., rs1801282) offer only weak, indirect clues and cannot replace standard blood work. Lifestyle interventions—Mediterranean diet, regular exercise, weight management—are first-line. Hormone replacement therapy (HRT) can improve lipids but requires individualized risk-benefit assessment. Caveat: evidence is strong, but individual factors (family history, inflammation) are critical. No single genetic test can predict menopause-related LDL changes.